
Uncategorized
Investment Plan for Europe: EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m
The European Investment Bank (EIB) and Newron Pharmaceuticals S.p.A. (Newron) (SIX: NWRN), a biophar...
30th October, 2018

The European Investment Bank (EIB) and Newron Pharmaceuticals S.p.A. (Newron) (SIX: NWRN), a biophar...
30th October, 2018

CurrencyFair, a leading provider of International Money Transfer services to consumers and businesse...
9th August, 2018